Tivic Health (TIVC) director adds 19,000 shares in open-market buy

Filing Impact

(Neutral)

Filing Sentiment

(Positive)

Form Type

Rhea-AI Filing Summary

Tivic Health Systems director Christina Rizopoulos Valauri made an open-market purchase of company stock. She bought 19,000 shares of Tivic Health Systems, Inc. Common Stock on April 1, 2026 at a price of $0.9478 per share. After this transaction, she directly owns 19,000 shares.

Insider Trade Summary

Net Buyer: 19,000 shares ($18,008)

Net Buy 1 txn

Insider Valauri Christina Rizopoulos

Role Director

Bought 19,000 shs ($18K)

Type	Security	Shares	Price	Value
Purchase	Common Stock	19,000	$0.9478	$18K

Holdings After Transaction: Common Stock — 19,000 shares (Direct)

Footnotes (1)

Key Figures

Shares purchased: 19,000 shares Purchase price: $0.9478 per share Shares owned after transaction: 19,000 shares

3 metrics

Shares purchased 19,000 shares Open-market purchase of Common Stock on April 1, 2026

Purchase price $0.9478 per share Price paid for Tivic Health Systems Common Stock

Shares owned after transaction 19,000 shares Direct holdings following the reported Form 4 transaction

Key Terms

open-market purchase, Common Stock, Form 4

3 terms

open-market purchase financial

"reported as an open-market purchase of 19,000 shares at $0.9478"

An open-market purchase is when an investor or a company buys shares on a public stock exchange at the going market price, rather than through a private deal. It matters to investors because these purchases change how many shares are available, can push the stock price up or signal confidence from large buyers, and often affect per-share metrics like earnings—think of it like someone buying lots of apples off a grocery shelf, reducing supply and potentially raising the price.

Common Stock financial

"19,000 shares of Tivic Health Systems, Inc. Common Stock"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

Form 4 regulatory

"according to a Form 4"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

Form 4 Insider Transactions: What Each Field Means →

04/02/2026 - 09:49 AM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Valauri Christina Rizopoulos

(Last)

(First)

(Middle)

1305 E. HOUSTON ST.

BLG. 1, STE. 311

(Street)

SAN ANTONIO

TEXAS

78205

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Tivic Health Systems, Inc. [ TIVC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	04/01/2026		P		19,000	A	$0.9478	19,000	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

	/s/ Christina R. Valauri	04/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did Tivic Health Systems (TIVC) report?

Tivic Health Systems reported that director Christina Rizopoulos Valauri bought 19,000 shares of Common Stock in an open-market purchase. The transaction took place at a price of $0.9478 per share, increasing her directly held position to 19,000 shares.

Who is the insider buying Tivic Health Systems (TIVC) shares?

Director Christina Rizopoulos Valauri is the insider buying Tivic Health Systems shares. She completed an open-market purchase of 19,000 Common Stock shares at $0.9478 per share, and now directly holds 19,000 shares following this reported transaction.

How many Tivic Health Systems (TIVC) shares were purchased and at what price?

The Form 4 shows a purchase of 19,000 Tivic Health Systems Common Stock shares at $0.9478 per share. This open-market transaction was reported as a direct holding, bringing the director’s total directly owned shares to 19,000 after the trade.

Is the Tivic Health Systems (TIVC) insider transaction a buy or a sell?

The reported Tivic Health Systems insider transaction is a buy. Director Christina Rizopoulos Valauri executed an open-market purchase of 19,000 Common Stock shares at $0.9478 per share, resulting in direct ownership of 19,000 shares after the transaction.

How did the Tivic Health Systems (TIVC) director’s holdings change in this Form 4?

After the reported transaction, the Tivic Health Systems director directly owns 19,000 shares. She acquired 19,000 Common Stock shares in an open-market purchase at $0.9478 per share, and the total shares following the transaction are listed as 19,000.

Tivic Health (TIVC) director adds 19,000 shares in open-market buy

Rhea-AI Filing Summary

Positive